Recursion outlines extended cash runway into early 2028 as platform efficiency accelerates

Ooops... Something went wrong while loading this page.
The Caledonian-Record

Recursion to Participate in Upcoming Investor Conferences

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the ...